HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dan Frenkel Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

6/2012Expression of scavenger receptor A on antigen presenting cells is important for CD4+ T-cells proliferation in EAE mouse model.
11/2008New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity.
4/2006Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dan Frenkel Research Topics

Disease

21Alzheimer Disease (Alzheimer's Disease)
01/2021 - 04/2002
7Cognitive Dysfunction
01/2017 - 01/2011
7Inflammation (Inflammations)
02/2015 - 12/2003
4Amyloid Plaque
05/2020 - 04/2002
4Disease Progression
01/2020 - 04/2008
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2015 - 06/2006
4Amyloidosis
05/2013 - 02/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 04/2008
3Neuroinflammatory Diseases
01/2020 - 09/2014
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2012 - 04/2006
3Infarction (Infarctions)
07/2009 - 12/2003
2Dementia (Dementias)
09/2014 - 09/2010
2Ischemic Stroke
05/2013 - 12/2003
2Hemorrhagic Stroke
05/2013 - 02/2012
2Autoimmune Diseases (Autoimmune Disease)
11/2008 - 06/2006
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2005 - 12/2003
2Stroke (Strokes)
06/2005 - 12/2003
1Weight Gain
01/2022
1Hypoglycemia (Reactive Hypoglycemia)
01/2022
1Hyperhomocysteinemia
01/2021
1Pathologic Processes
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2020
1Gliosis
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Neuroblastoma
01/2017
1Deglutition Disorders (Dysphagia)
11/2016
1Muscular Diseases (Myopathy)
11/2016
1Metabolic Diseases (Metabolic Disease)
12/2015
1Diabetes Mellitus
12/2015
1Infections
05/2014
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
05/2013
1Phenylketonurias (Phenylketonuria)
08/2012
1Intellectual Disability (Idiocy)
08/2012
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2011
1Dehydration (Water Stress)
01/2011
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2009
1Reperfusion Injury
07/2009
1Cytokine Release Syndrome
11/2008
1Autoimmune Diseases of the Nervous System
08/2007
1Meningoencephalitis
05/2006

Drug/Important Bio-Agent (IBA)

14Amyloid (Amyloid Fibrils)IBA
01/2021 - 03/2003
7Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2003
7Peptides (Polypeptides)IBA
01/2021 - 12/2003
6Amyloid beta-PeptidesIBA
09/2010 - 04/2002
5Interleukin-10 (Interleukin 10)IBA
09/2014 - 12/2003
4Scavenger Receptors (Scavenger Receptor)IBA
01/2018 - 06/2012
4AntibodiesIBA
05/2014 - 04/2002
3CytokinesIBA
01/2020 - 09/2014
3Monoclonal AntibodiesIBA
11/2008 - 06/2006
3Myelin-Oligodendrocyte GlycoproteinIBA
04/2008 - 12/2003
2Insulin (Novolin)FDA Link
01/2022 - 12/2015
2Interferon-gamma (Interferon, gamma)IBA
01/2020 - 05/2010
2AntigensIBA
01/2020 - 06/2005
2Neuroprotective AgentsIBA
01/2017 - 04/2008
1PolyphenolsIBA
01/2021
1HomocysteineIBA
01/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2020
1alpha-SynucleinIBA
01/2020
1InterleukinsIBA
01/2020
1rasagiline (Azilect)FDA Link
01/2017
1Monoamine Oxidase (MAO)IBA
01/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2017
1Scopolamine (Hyoscine)FDA Link
01/2017
1Serotonin (5 Hydroxytryptamine)IBA
01/2017
1Cholinesterases (Cholinesterase)IBA
01/2017
1Rivastigmine (Exelon)FDA LinkGeneric
01/2017
1Epidermal Growth Factor (EGF)IBA
11/2016
1Blood Glucose (Blood Sugar)IBA
12/2015
1Interleukin-6 (Interleukin 6)IBA
09/2014
1Cytokine Receptors (Cytokine Receptor)IBA
09/2014
1SynaptophysinIBA
05/2013
1Insulysin (Insulin-Degrading Enzyme)IBA
05/2013
1TOR Serine-Threonine KinasesIBA
01/2013
1Glycogen Synthase (Synthase I)IBA
01/2013
1Phenylalanine (L-Phenylalanine)FDA Link
08/2012
1Amino AcidsFDA Link
08/2012
1Retinaldehyde (Retinal)IBA
09/2011
1Protein Kinases (Protein Kinase)IBA
09/2011
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2011
1amyloid beta-protein (1-42)IBA
05/2010
1Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2010
1Protein Isoforms (Isoforms)IBA
07/2009
1TroponinIBA
07/2009
1Troponin CIBA
07/2009
1AntioxidantsIBA
04/2008
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2008
1FullerenesIBA
04/2008
1Streptozocin (Streptozotocin)FDA Link
08/2007
1Transforming Growth Factor beta (TGF-beta)IBA
04/2006

Therapy/Procedure

7Immunotherapy
02/2012 - 05/2006
6Therapeutics
01/2015 - 06/2005
3Oral Administration
11/2008 - 12/2003
2Intranasal Administration
05/2020 - 07/2009
2Transplantation
11/2008 - 06/2006
1Hyperbaric Oxygenation
01/2018
1Subcutaneous Injections
12/2015
1Low-Level Light Therapy (LLLT)
02/2015